Cent Eur Neurosurg 2010; 71(2): 80-87
DOI: 10.1055/s-0029-1234040
Review

© Georg Thieme Verlag KG Stuttgart · New York

Essentials and Pitfalls in the Treatment of CNS Hemangioblastomas and von Hippel-Lindau Disease

S. Gläsker1 , J. H. Klingler1 , K. Müller2 , C. Würtenberger1 , C. Hader3 , J. Zentner1 , H. P. H. Neumann4 , V. Van Velthoven1
  • 1Department of Neurosurgery, Freiburg University Medical Center, Freiburg, Germany
  • 2Department of Neuropathology, Freiburg University Medical Center, Freiburg, Germany
  • 3Department of Neuroradiology, Freiburg University Medical Center, Freiburg, Germany
  • 4Department of Nephrology and Hypertension, Freiburg University Medical Center, Freiburg, Germany
Further Information

Publication History

Publication Date:
12 March 2010 (online)

Abstract

Hemangioblastomas are rare CNS tumors, which are mostly located in the posterior fossa or spinal cord and occasionally in spinal nerves. They can occur sporadically or as a component tumor of von Hippel-Lindau (VHL) disease, an autosomal dominant tumor syndrome. The limited awareness of several pitfalls in the therapy of these rare lesions results in delayed or suboptimal treatment for many of these patients, especially those with VHL disease. The University of Freiburg serves as a reference center for patients with VHL disease and hemangioblastomas. The current therapeutic strategies for hemangioblastoma patients and typical pitfalls are presented here.

References

  • 1 Adams SA, Hilton DA. Recurrent haemangioblastoma with glial differentiation.  Neuropathology & Applied Neurobiology. 2002;  28 ((2)) 142-146
  • 2 Baker KB, Moran CJ, Wippold 2nd FJ. et al . MR imaging of spinal hemangioblastoma.  Am J Roentgenol. 2000;  174 ((2)) 377-382
  • 3 Bakshi R, Mechtler LL, Patel MJ. et al . Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings.  J Neuroimaging. 1997;  7 ((4)) 242-244
  • 4 Becker I, Paulus W, Roggendorf W. Histogenesis of stromal cells in cerebellar hemangioblastomas.  Am J Pathol. 1989;  134 271-275
  • 5 Bleistein M, Geiger K, Franz K. et al . Transthyretin and transferrin in hemangioblastoma stromal cells.  Pathology, Research & Practice. 2000;  196 ((10)) 675-681
  • 6 Bohling T, Plate KH, Haltia M. et al .Von Hippel-Lindau disease and capillary hemangioblastoma.. In: Pathology and Genetics of Tumours of the Central Nervous System., Kleihues P, Cawenee WK, (eds) Lyon: World Health Organization; 2000. pp. 223-226
  • 7 Chang SD, Meisel JA, Hancock SL. et al . Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery.  Neurosurgery. 1998;  43 ((1)) 28-34 discussion 34–35
  • 8 Collins E. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes).  Trans Ophthalmol Soc UK. 1894;  14 141-149
  • 9 Conway JE, Chou D, Clatterbuck RE. et al . Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.  Neurosurgery. 2001;  48 ((1)) 55-62 discussion 62–63
  • 10 Cornelius JF, Saint-Maurice JP, Bresson D. et al . Hemorrhage after particle embolization of hemangioblastomas: comparison of outcomes in spinal and cerebellar lesions.  J Neurosurg. 2007;  106 ((6)) 994-998
  • 11 Cristante L, Herrmann HD. Surgical management of intramedullary hemangioblastoma of the spinal cord.  Acta Neurochir (Wien). 1999;  141 ((4)) 333-339 discussion 339–340
  • 12 Cushing H, Bailey P. Hemangiomas of cerebellum and retina (Lindau's disease).  Arch Ophthalmol. 1928;  57 447-463
  • 13 de la Monte SM, Horowitz SA. Hemangioblastomas: clinical and histopathological factors correlated with recurrence.  Neurosurgery. 1989;  25 ((5)) 695-698
  • 14 Decq P. Guidelines for the maintenance of Hippel-Lindau disease in daily practice. French Society of Neurosurgery.  Neurochirurgie. 1998;  44 ((4)) 273-274
  • 15 Eskridge JM, McAuliffe W, Harris B. et al . Preoperative endovascular embolization of craniospinal hemangioblastomas.  Am J Neuroradiol. 1996 17 ((3)) 525-531
  • 16 Filling-Katz MR, Choyke PL, Oldfield E. et al . Central nervous system involvement in Von Hippel-Lindau disease.  Neurology. 1991;  41 ((1)) 41-46
  • 17 Frank TS, Trojanowski JQ, Roberts SA. et al . A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor.  Mod Pathol. 1989;  2 ((6)) 638-651
  • 18 Friedrich H, Hansel-Friedrich G, Zeumer H. Intramedullary vascular lesions in the high cervical region: transoral and dorsal surgical approach. Two case reports.  Neurosurg Rev. 1990;  13 ((1)) 65-71
  • 19 Girmens JF, Erginay A, Massin P. et al . Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.  Am J Ophthalmol. 2003;  136 ((1)) 194-196
  • 20 Glasker S, Bender BU, Apel TW. et al . The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.  J Neurol Neurosurg Psychiatry. 1999;  67 ((6)) 758-762
  • 21 Glasker S, Berlis A, Pagenstecher A. et al . Characterization of hemangioblastomas of spinal nerves.  Neurosurgery. 2005;  56 ((3)) 503-509
  • 22 Glasker S, Li J, Xia JB. et al . Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell.  Cancer Research. 2006;  66 ((8)) 4167-4172
  • 23 Glasker S, Lonser RR, Okamoto H. et al . Proteomic profiling – a novel method for differential diagnosis?.  Cancer Biol Ther. 2007;  6 ((3)) 343-345
  • 24 Glasker S, Lonser RR, Tran MG. et al . Effects of VHL deficiency on endolymphatic duct and sac.  Cancer Research. 2005;  65 ((23)) 10847-10853
  • 25 Glasker S, Sohn TS, Okamoto H. et al . Second hit deletion size in von Hippel-Lindau disease.  Ann Neurol. 2006;  59 ((11)) 105-110
  • 26 Glasker S, Tran MG, Shively SB. et al . Epididymal cystadenomas and epithelial tumorlets: Effects of VHL deficiency on human epididymis.  J Pathol. 2006;  210 ((1)) 32-41
  • 27 Glasker S, van Velthoven V. Risk of hemorrhage in hemangioblastomas of the central nervous system.  Neurosurgery. 2005;  57 ((1)) 71-76
  • 28 Glasker S, Vortmeyer AO, Lonser RR. et al . Proteomic analysis of hemangioblastoma cyst fluid.  Cancer Biol Ther. 2006;  5 ((5)) 549-553
  • 29 Governale LS, Vortmeyer AO, Zhuang Z. et al . Fibrous meningioma in a patient with von Hippel-Lindau disease: a genetic analysis.  J Neurosurg. 2001;  95 ((6)) 1045-1049
  • 30 Ironside JW, Stephenson TJ, Royds JA. Stromal cells in cerebellar hemangioblastomas: An immunohistochemical study.  Histopathology. 1988;  12 29-40
  • 31 Jacobiec FA, Font RL, Johnson FB. Angiomatosis retinae: An ultrastructural study and lipid analysis.  Cancer. 1976;  38 2042-2056
  • 32 Jarrell ST, Vortmeyer AO, Linehan WM. et al . Metastases to hemangioblastomas in von Hippel-Lindau disease.  J Neurosurg. 2006;  105 ((2)) 256-263
  • 33 Jawahar A, Kondziolka D, Garces YI. et al . Stereotactic radiosurgery for hemangioblastomas of the brain.  Acta Neurochir. 2000;  142 ((6)) 641-644
  • 34 Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma.  Mod Pathol. 2005;  18 ((5)) 788-794
  • 35 Jurco 3rd S, Nadji M, Harvey DG. et al . Hemangioblastomas: histogenesis of the stromal cell studied by immunocytochemistry.  Hum Pathol. 1982;  13 ((1)) 13-18
  • 36 Kanno H, Yamamoto I, Yoshida M. et al . Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.  Neurology. 2003;  60 ((7)) 1197-1199
  • 37 Kepes JJ, Rengachary SS, Lee SH. Astrocytes in hemangioblastomas of the central nervous system and their relationship to stromal cells.  Acta Neuropathol (Berl). 1979;  47 ((2)) 99-104
  • 38 Krishnan KG, Schackert G. Outcomes of surgical resection of large solitary hemangioblastomas of the craniocervical junction with limitations in preoperative angiographic intervention: report of three cases.  Zentralbl Neurochir. 2006;  67 ((3)) 137-143
  • 39 Lamiell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred.  Medicine (Baltimore). 1989;  68 ((1)) 1-29
  • 40 Lantos PL, Louis DN, Rosenblum MK. et al .Tumors of the nervous system.. In: Greenfield's Pathology Graham DI, Lantos PL, (eds) London: Arnold; 2002. pp. 767-1052
  • 41 Lindau A. Zur Frage der Angiomatosis retinae und ihrer Hirnkomplikation.  Acta Ophthalmol (Copenh). 1927;  4 193-226
  • 42 Lonser R, Weil R, Wanebo J. et al . Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease.  J Neurosurg. 2003;  98 ((1)) 106-116
  • 43 Lonser RR, Kim HJ, Butman JA. et al . Tumors of the endolymphatic sac in von Hippel-Lindau disease.  N Engl J Med. 2004;  350 ((24)) 2481-2486
  • 44 Lonser RR, Oldfield EH. Microsurgical resection of spinal cord hemangioblastomas.  Neurosurgery. 2005;  57 ((4)) 372-376
  • 45 Lonser RR, Vortmeyer AO, Butman JA. et al . Edema is a precursor to central nervous system peritumoral cyst formation.  Annals of Neurology. 2005;  58 392-399
  • 46 Maddock IR, Moran A, Maher ER. et al . A genetic register for von Hippel-Lindau disease.  J Med Genet. 1996;  33 ((2)) 120-127
  • 47 Madhusudan S, Deplanque G, Braybrooke JP. et al . Antiangiogenic therapy for von Hippel-Lindau disease.  JAMA. 2004;  291 ((8)) 943-944
  • 48 Maher ER, Yates JR, Harries R. et al . Clinical features and natural history of von Hippel-Lindau disease [see comments].  Q J Med. 1990;  77 ((283)) 1151-1163
  • 49 Malis LI. Atraumatic bloodless removal of intramedullary hemangioblastomas of the spinal cord.  J Neurosurg (Spine). 2002;  97 1-6
  • 50 Melmon KL, Rosen SW. Lindau's disease: Review of the literature and study of a large kindred.  Am J Med. 1964;  36 595-617
  • 51 Mizuno J, Iwata K, Takei Y. Immunohistochemical study of hemangioblastoma with special reference to its cytogenesis.  Neurol Med Chir (Tokyo). 1993;  33 ((7)) 420-444
  • 52 Nau JA, Shields CL, Shields JA. et al . Optic nerve glioma in a patient with von Hippel-Lindau syndrome.  J Pediatr Ophthalmol Strabismus. 2003;  40 ((1)) 57-58
  • 53 Nemes Z. Fibrohistiocytic differentiation in capillary hemangioblastoma.  Hum Pathol. 1992;  23 ((7)) 805-810
  • 54 Neumann HP. Prognosis of von Hippel-Lindau syndrome.  Vasa. 1987;  16 ((4)) 309-311
  • 55 Neumann HP, Cybulla M, Glasker S. et al . Von Hippel-Lindau disease: Interdisciplinary patient care.  Ophthalmologe. 2007;  104 ((2)) 119-126
  • 56 Neumann HP, Eggert HR, Weigel K. et al . Hemangioblastomas of the central nervous system. A 10-year study with special reference to von.  Hippel-Lindau syndrome. J Neurosurg. 1989;  70 ((1)) 24-30
  • 57 Ng HK, Tse JY, Poon WS. Cerebellar astrocytoma associated with von Hippel-Lindau disease: case report with molecular findings.  Br J Neurosurg. 1999;  13 ((5)) 504-507
  • 58 Niemela M, Lim YJ, Soderman M. et al . Gamma knife radiosurgery in 11 hemangioblastomas.  J Neurosurg. 1996;  85 ((4)) 591-596
  • 59 Ohtakara K, Kuga Y, Murao K. et al . Preoperative embolization of upper cervical cord hemangioblastoma concomitant with venous congestion – case report.  Neurol Medic Chirurg. 2000;  40 ((11)) 589-593
  • 60 Pan L, Wang EM, Wang BJ. et al . Gamma knife radiosurgery for hemangioblastomas.  Stereotact Funct Neurosurg. 1998;  70 (S 01) 179-186
  • 61 Patrice SJ, Sneed PK, Flickinger JC. et al . Radiosurgery for hemangioblastoma: results of a multiinstitutional experience.  Int J Radiat Oncol Biol Phys. 1996;  35 ((3)) 493-499
  • 62 Pietila TA, Stendel R, Schilling A. et al . Surgical treatment of spinal hemangioblastomas.  Acta Neurochir (Wien). 2000;  142 879-886
  • 63 Resche F, Moisan JP, Mantoura J. et al . Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease.  Adv Tech Stand Neurosurg. 1993;  20 197-304
  • 64 Spetzger U, Bertalanffy H, Huffmann B. et al . Hemangioblastomas of the spinal cord and the brainstem: diagnostic and therapeutic features.  Neurosurg Rev. 1996;  19 ((3)) 147-151
  • 65 Standard SC, Ahuja A, Livingston K. et al . Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas.  Surg Neurol. 1994;  41 ((5)) 405-410
  • 66 Tampieri D, Leblanc R, TerBrugge K. Preoperative embolization of brain and spinal hemangioblastomas.  Neurosurgery. 1993;  33 ((3)) 502-505 discussion 505
  • 67 Tanimura A, Nakamura Y, Hachisuka H. et al . Hemangioblastoma of the central nervous system: nature of the stromal cells as studied by the immunoperoxidase technique.  Hum Pathol. 1984;  15 ((9)) 866-869
  • 68 Theunissen PH, Debets-Te Baerts M, Blaauw G. Histogenesis of intracranial haemangiopericytoma and haemangioblastoma.  An immunohistochemical study. Acta Neuropathol (Berl). 1990;  80 ((1)) 68-71
  • 69 van Velthoven V, Reinacher PC, Klisch J. et al . Treatment of intramedullary hemangioblastomas, with special attention to von Hippel-Lindau disease.  Neurosurgery. 2003;  53 ((6)) 1306-1313
  • 70 Vazquez-Anon V, Botella C, Beltran A. et al . Preoperative embolization of solid cervicomedullary junction hemangioblastomas: report of two cases.  Neuroradiology. 1997;  39 ((2)) 86-89
  • 71 von Hippel E. Über eine sehr seltene Erkrankung der Netzhaut.  von Graefe's Archiv für Ophthalmologie. 1904;  59 83-106
  • 72 Vortmeyer AO, Frank S, Jeong SY. et al . Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.  Cancer Research. 2003;  63 ((21)) 7051-7055
  • 73 Vortmeyer AO, Gnarra JR, Emmert-Buck MR. et al . von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.  Hum Pathol. 1997;  28 ((5)) 540-543
  • 74 Vortmeyer AO, Tran M, Zeng W. et al . Evolution of VHL tumorigenesis in nerve root tissue.  J Pathol. 2006;  210 ((3)) 374-382
  • 75 Vortmeyer AO, Weil RJ, Zhuang Z. Proteomic applications for differential diagnosis of histologically identical tumors.  Neurology. 2003;  61 ((11)) 1626-1627
  • 76 Wanebo J, Lonser R, Glenn G. et al . The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.  J Neurosurg. 2003;  98 ((1)) 82-94
  • 77 Weil R, Lonser R, DeVroom H. et al . Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease.  J Neurosurg. 2003;  98 ((1)) 95-105
  • 78 Weil RJ, Vortmeyer AO, Zhuang Z. et al . Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.  J Neurosurg. 2002;  96 ((4)) 775-787
  • 79 Wizigmann-Voos S, Breier G, Risau W. et al . Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease – associated and sporadic hemangioblastomas.  Cancer Research. 1995;  55 ((6)) 1358-1364
  • 80 Woodward ER, Wall K, Forsyth J. et al . VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.  Brain. 2007;  130 ((Pt 3)) 836-342
  • 81 Xu QW, Bao WM, Mao RL. et al . Magnetic resonance imaging and microsurgical treatment of intramedullary hemangioblastoma of the spinal cord.  Neurosurgery. 1994;  35 ((4)) 671-675

Correspondence

Prof. Dr. V. Van Velthoven

Neurozentrum

Neurosurgery

Breisacher Straße 64

79106 Freiburg

Germany

Phone: 00 49 761 2705023

Fax: 00 49 761 2705017

Email: vera.van-velthoven@uniklinik-freiburg.de